Virtual reality and hypnosis tested as anxiety relief for leukemia patients
NCT ID NCT07386392
First seen Feb 04, 2026 · Last updated Jun 12, 2026 · Updated 19 times
Summary
This study looks at whether medical hypnosis or virtual reality can reduce anxiety in adults with acute myeloid leukemia during their first round of chemotherapy. About 99 participants will be split into three groups: standard care alone, standard care plus hypnosis, or standard care plus virtual reality. The goal is to see if these relaxation techniques help patients feel less anxious and cope better with the stress of diagnosis and treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IUCT Oncopole
Toulouse, France, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.